- Home
- SRZN vs CDLX Comparison
SRZN vs CDLX Comparison
Compare SRZN & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- CDLX
- Stock Information
- Founded
- SRZN 2015
- CDLX 2008
- Country
- SRZN United States
- CDLX United States
- Employees
- SRZN N/A
- CDLX N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- CDLX Computer Software: Programming Data Processing
- Sector
- SRZN Health Care
- CDLX Technology
- Exchange
- SRZN Nasdaq
- CDLX Nasdaq
- Market Cap
- SRZN 97.3M
- CDLX 93.5M
- IPO Year
- SRZN N/A
- CDLX 2018
- Fundamental
- Price
- SRZN $12.55
- CDLX $0.91
- Analyst Decision
- SRZN Strong Buy
- CDLX Hold
- Analyst Count
- SRZN 2
- CDLX 3
- Target Price
- SRZN $38.50
- CDLX $2.25
- AVG Volume (30 Days)
- SRZN 16.1K
- CDLX 1.6M
- Earning Date
- SRZN 08-08-2025
- CDLX 08-06-2025
- Dividend Yield
- SRZN N/A
- CDLX N/A
- EPS Growth
- SRZN N/A
- CDLX N/A
- EPS
- SRZN N/A
- CDLX N/A
- Revenue
- SRZN $12,621,000.00
- CDLX $266,201,000.00
- Revenue This Year
- SRZN N/A
- CDLX N/A
- Revenue Next Year
- SRZN N/A
- CDLX N/A
- P/E Ratio
- SRZN N/A
- CDLX N/A
- Revenue Growth
- SRZN N/A
- CDLX N/A
- 52 Week Low
- SRZN $5.90
- CDLX $0.85
- 52 Week High
- SRZN $18.17
- CDLX $5.25
- Technical
- Relative Strength Index (RSI)
- SRZN 70.80
- CDLX 31.88
- Support Level
- SRZN $10.73
- CDLX $0.85
- Resistance Level
- SRZN $11.88
- CDLX $1.12
- Average True Range (ATR)
- SRZN 0.73
- CDLX 0.09
- MACD
- SRZN 0.09
- CDLX 0.00
- Stochastic Oscillator
- SRZN 74.09
- CDLX 12.69
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.